These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

354 related items for PubMed ID: 15282698

  • 1. Esophageal cancer: outcomes of surgery, neoadjuvant chemotherapy, and three-dimension conformal radiotherapy.
    Fréchette E, Buck DA, Kaplan BJ, Chung TD, Shaw JE, Kachnic LA, Neifeld JP.
    J Surg Oncol; 2004 Aug 01; 87(2):68-74. PubMed ID: 15282698
    [Abstract] [Full Text] [Related]

  • 2. Induction chemotherapy improved outcomes of patients with resectable esophageal cancer who received chemoradiotherapy followed by surgery.
    Jin J, Liao Z, Zhang Z, Ajani J, Swisher S, Chang JY, Jeter M, Guerrero T, Stevens CW, Vaporciyan A, Putnam J, Walsh G, Smythe R, Roth J, Yao J, Allen P, Cox JD, Komaki R.
    Int J Radiat Oncol Biol Phys; 2004 Oct 01; 60(2):427-36. PubMed ID: 15380576
    [Abstract] [Full Text] [Related]

  • 3. Neoadjuvant chemoradiation versus chemotherapy for patients undergoing esophagectomy for esophageal cancer.
    Luu TD, Gaur P, Force SD, Staley CA, Mansour KA, Miller JI, Miller DL.
    Ann Thorac Surg; 2008 Apr 01; 85(4):1217-23; discussion 1223-4. PubMed ID: 18355499
    [Abstract] [Full Text] [Related]

  • 4. Only pathologic complete response to neoadjuvant chemotherapy improves significantly the long term survival of patients with resectable esophageal squamous cell carcinoma: final report of a randomized, controlled trial of preoperative chemotherapy versus surgery alone.
    Ancona E, Ruol A, Santi S, Merigliano S, Sileni VC, Koussis H, Zaninotto G, Bonavina L, Peracchia A.
    Cancer; 2001 Jun 01; 91(11):2165-74. PubMed ID: 11391598
    [Abstract] [Full Text] [Related]

  • 5. Phase II study of preoperative paclitaxel/cisplatin with radiotherapy in locally advanced esophageal cancer.
    Kim DW, Blanke CD, Wu H, Shyr Y, Berlin J, Beauchamp RD, Chakravarthy B.
    Int J Radiat Oncol Biol Phys; 2007 Feb 01; 67(2):397-404. PubMed ID: 17097833
    [Abstract] [Full Text] [Related]

  • 6. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR, Suntharalingam M, Edelman MJ, Patel AB, Gamliel Z, Doyle A, Hausner P, Krasna M.
    Ann Thorac Surg; 2004 Oct 01; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [Abstract] [Full Text] [Related]

  • 7. Multimodality treatment for esophageal cancer: the role of surgery and neoadjuvant therapy.
    Makary MA, Kiernan PD, Sheridan MJ, Tonnesen G, Hetrick V, Vaughan B, Graling P, Elster E.
    Am Surg; 2003 Aug 01; 69(8):693-700; discussion 700-2. PubMed ID: 12953828
    [Abstract] [Full Text] [Related]

  • 8. Twice-daily radiotherapy as concurrent boost technique during two chemotherapy cycles in neoadjuvant chemoradiotherapy for resectable esophageal carcinoma: mature results of phase II study.
    Choi N, Park SD, Lynch T, Wright C, Ancukiewicz M, Wain J, Donahue D, Mathisen D.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):111-22. PubMed ID: 15337546
    [Abstract] [Full Text] [Related]

  • 9. Selective dose escalation of chemoradiotherapy for esophageal cancer: role of treatment intensification.
    Seung SK, Smith JW, Molendyk J, Bader SB, Phillips M, Regan J, Louie J, Soo E, Seligman M, Ruzich J, Skokan L, Ross HJ.
    Semin Oncol; 2004 Dec 01; 31(6 Suppl 18):13-9. PubMed ID: 15726517
    [Abstract] [Full Text] [Related]

  • 10. Neoadjuvant chemoradiotherapy for locally advanced esophageal cancer: experience at a single institution.
    Malaisrie SC, Untch B, Aranha GV, Mohideen N, Hantel A, Pickleman J.
    Arch Surg; 2004 May 01; 139(5):532-8; discussion 538-9. PubMed ID: 15136354
    [Abstract] [Full Text] [Related]

  • 11. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Stevens CW, Ho L, Smythe R, Vaporciyan AA, Putnam JB, Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R.
    Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1484-93. PubMed ID: 15590179
    [Abstract] [Full Text] [Related]

  • 12. Concurrent cisplatin, 5-FU, paclitaxel, and radiation therapy in patients with locally advanced esophageal cancer.
    Roof KS, Coen J, Lynch TJ, Wright C, Fidias P, Willett CG, Choi NC.
    Int J Radiat Oncol Biol Phys; 2006 Jul 15; 65(4):1120-8. PubMed ID: 16730135
    [Abstract] [Full Text] [Related]

  • 13. Neoadjuvant therapy for esophageal cancer: standard of care or elusive myth?
    Boyle MJ, Franceschi D, Robinson DS, Livingstone AS.
    Am Surg; 2001 Oct 15; 67(10):956-65. PubMed ID: 11603553
    [Abstract] [Full Text] [Related]

  • 14. Toxicity and outcome of a phase II trial of taxane-based neoadjuvant chemotherapy and 3-dimensional, conformal, accelerated radiotherapy in locally advanced nonsmall cell lung cancer.
    Rojas AM, Lyn BE, Wilson EM, Williams FJ, Shah N, Dickson J, Saunders MI.
    Cancer; 2006 Sep 15; 107(6):1321-30. PubMed ID: 16902985
    [Abstract] [Full Text] [Related]

  • 15. [Short and long-term outcomes of neoadjuvant chemotherapy for locally advanced esophageal carcinoma].
    Xie MR, Zhang X, Lin P, Lin YB, Rong TH, Zhang LJ, Wen ZS, Li XD.
    Zhonghua Yi Xue Za Zhi; 2009 Nov 10; 89(41):2906-9. PubMed ID: 20137647
    [Abstract] [Full Text] [Related]

  • 16. Long-term results of a phase II trial of neoadjuvant chemotherapy followed by esophagectomy for locally advanced esophageal neoplasm.
    Pennathur A, Luketich JD, Landreneau RJ, Ward J, Christie NA, Gibson MK, Schuchert M, Cooper K, Land SR, Belani CP.
    Ann Thorac Surg; 2008 Jun 10; 85(6):1930-6; discussion 1936-7. PubMed ID: 18498797
    [Abstract] [Full Text] [Related]

  • 17. A retrospective analysis of locally advanced esophageal cancer patients treated with neoadjuvant chemoradiation therapy followed by surgery or surgery alone.
    Kesler KA, Helft PR, Werner EA, Jain NP, Brooks JA, DeWitt JM, Leblanc JK, Fineberg NS, Einhorn LH, Brown JW.
    Ann Thorac Surg; 2005 Apr 10; 79(4):1116-21. PubMed ID: 15797035
    [Abstract] [Full Text] [Related]

  • 18. [Initial outcome of induction chemotherapy with weekly paclitaxel followed by three-dimensional conformal radiotherapy and concurrent weekly paclitaxel for stage III non-small cell lung cancer].
    Wang WH, Bao Y, Chen M, Zhang L, Li KX, Xu GC, Deng XW, Lu TX, Cui NJ.
    Ai Zheng; 2006 Oct 10; 25(10):1279-83. PubMed ID: 17059776
    [Abstract] [Full Text] [Related]

  • 19. En bloc esophagectomy reduces local recurrence and improves survival compared with transhiatal resection after neoadjuvant therapy for esophageal adenocarcinoma.
    Rizzetto C, DeMeester SR, Hagen JA, Peyre CG, Lipham JC, DeMeester TR.
    J Thorac Cardiovasc Surg; 2008 Jun 10; 135(6):1228-36. PubMed ID: 18544359
    [Abstract] [Full Text] [Related]

  • 20. Downstaging of T or N predicts long-term survival after preoperative chemotherapy and radical resection for esophageal carcinoma.
    Korst RJ, Kansler AL, Port JL, Lee PC, Kerem Y, Altorki NK.
    Ann Thorac Surg; 2006 Aug 10; 82(2):480-4; discussion 484-5. PubMed ID: 16863749
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.